Research and Markets: Acute Inflammation - Pipeline Review, H2 2013 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7hmrjn/acute) has announced the addition of the "Acute Inflammation - Pipeline Review, H2 2013" report to their offering.

'Acute Inflammation - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Inflammation.

Scope

- A snapshot of the global therapeutic scenario for Acute Inflammation.

- A review of the Acute Inflammation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Acute Inflammation pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Acute Inflammation Overview

Therapeutics Development

Pipeline Products for Acute Inflammation - Overview

Pipeline Products for Acute Inflammation - Comparative Analysis

Acute Inflammation - Therapeutics under Development by Companies

Acute Inflammation - Therapeutics under Investigation by Universities/Institutes

Acute Inflammation - Pipeline Products Glance

Early Stage Products

Unknown Stage Products

Acute Inflammation - Products under Development by Companies

Acute Inflammation - Products under Investigation by Universities/Institutes

Acute Inflammation - Companies Involved in Therapeutics Development

Acute Inflammation - Therapeutics Assessment

Drug Profiles

ATL-1222 - Drug Profile

CGEN-856 - Drug Profile

ADC-1004 - Drug Profile

DF-2156A - Drug Profile

AN-3485 - Drug Profile

PIN-201104 - Drug Profile

GB-88 - Drug Profile

Distamycin Derivatives - Drug Profile

Selective Inhibitor of Pro Inflammatory Cytokine - Drug Profile

Appendix

Companies Mentioned

BioLineRx, Ltd.

Forest Laboratories, Inc.

Italfarmaco S.p.A.

Alligator Bioscience AB

Anacor Pharmaceuticals, Inc.

Dompe Farmaceutici S.p.A.

Peptinnovate Limited

For more information visit http://www.researchandmarkets.com/research/7hmrjn/acute

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders